New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2012
19:02 EDTEXAR, HBIO, DD, ACMP, MCP, MPEL, WMB, GEOS, AETOn The Fly: After Hours Movers
UP AFTER GUIDANCE: DuPont (DD), up 2.2% after saying it sees FY12 EPS at high end of previous guidance range... Aetna (AET), up 1.5% after backing FY12 EPS view... ALSO HIGHER: Melco Crown Entertainment (MPEL), up 2.8% after a Sterne Agee note positively mentioned the company's Macau casino operations... Harvard Bioscience (HBIO), up 5% after announcing one of its subsidiaries filed for an IPO... DOWN AFTER EARNINGS: Geospace Technologies (GEOS), down 11%... ALSO LOWER: Molycorp (MCP), down 7.7% after announcing its CEO was leaving the company... Exar (EXAR), down 7% after announcing the termination of its CFO... Williams (WMB) after announcing it was taking a $2.4B stake in Access Midstream Partners (ACMP).
News For DD;AET;MPEL;HBIO;GEOS;MCP;EXAR;WMB;ACMP From The Last 14 Days
Check below for free stories on DD;AET;MPEL;HBIO;GEOS;MCP;EXAR;WMB;ACMP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 21, 2013
16:04 EDTMCPOptions Update; May 21, 2013
Subscribe for More Information
11:34 EDTWMBHigh option volume stocks: JASO YGE WMB AMTD TSL
Subscribe for More Information
10:00 EDTAETOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:42 EDTMCPActive equity option families trading on open
Active equity option families trading on open according to Track Data: AAPL HD MCP ABX TSLA C
09:19 EDTMCPChina rare-earth exports rose 28% in April from prior month, WSJ says
Subscribe for More Information
06:04 EDTAETAetna reinstated with a Buy at Goldman
Target $68.
May 20, 2013
17:30 EDTWMBWilliams backs FY13, FY14 adjusted EPS views
In presentation slides ahead of an analyst day to be held May 21, Williams backed its FY13 and FY14 adjusted EPS views. The company sees FY13 adjusted EPS 73c, consensus 88c. The company sees FY14 adjusted EPS $1.30, consensus $1.30. The company also sees FY15 adjusted EPS $1.55. The company also backed its previously issued FY13-FY15 annual dividend guidance, saying it expects to pay an annual dividend of $1.44 in FY13, $1.75 in FY14, and $2.11 in FY15.
08:04 EDTDDBofA/Merrill's U.S. chemicals analyst holds an analyst/industry conference call
Subscribe for More Information
May 17, 2013
07:10 EDTACMPAccess Midstream is an underappreciated growth story, says Credit Suisse
Subscribe for More Information
May 16, 2013
16:26 EDTWMBWilliams raises dividend to 35.25c per share, backs FY13-FY15 dividend growth view
Subscribe for More Information
May 15, 2013
17:36 EDTAETPaulson gives quarterly update on stakes
Subscribe for More Information
14:36 EDTWMBWilliams to host analyst day
Subscribe for More Information
07:32 EDTHBIOHarvard Bioscience CEO retires, David Green named interim CEO
Subscribe for More Information
May 14, 2013
12:00 EDTAETAetna forms strategic alliance with Tawuniya
Subscribe for More Information
10:01 EDTMPELOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AVG Technologies (AVG) downgraded to Neutral from Buy at Goldman... Cigna (CI) downgraded to Hold from Buy at Jefferies... Cree (CREE) downgraded to Neutral from Buy at Sterne Agee... Melco Crown (MPEL) downgraded to Neutral from Buy at UBS... SolarCity (SCTY) downgraded to Neutral from Buy at Roth Capital... KB Home (KBH) downgraded to Market Perform from Outperform at Raymond James... Ryland Group (RYL) downgraded to Underperform from Market Perform at Raymond James... Alere (ALR) downgraded to Hold from Buy at Craig-Hallum... Evolution Petroleum (EPM) downgraded to Hold from Buy at MLV Equity... Oil States (OIS) downgraded to Hold from Buy at BB&T... VIVUS (VVUS) downgraded to Neutral from Buy at Lazard Capital.
07:23 EDTDDOppenheimer to host a summit
Subscribe for More Information
06:15 EDTMPELMelco Crown downgraded to Neutral from Buy at UBS
Subscribe for More Information
06:12 EDTDDSyngenta and DuPont announce technology license agreement
Syngenta (SYT) and DuPont (DD) announced technology licensing agreements that will broaden each company's crop protection product portfolio and enable both to bring new products to market more efficiently. Syngenta has obtained a global license from DuPont to develop products containing DuPont's fungicide oxathiapiprolin. Under the agreements, Syngenta receives exclusive rights for foliar and soil uses on all crops in North America and for lawn and garden uses globally. Syngenta also secures rights on certain crops for seed treatment globally and for the development of foliar and soil uses on certain crops outside of North America. The agreement gives DuPont exclusive access to Syngenta's Solatenol for mixture with DuPont's picoxystrobin fungicide on soybean and other crops in Brazil. Solatenol is a new benz-pyrazole SDHI fungicide which brings a new mode of action with no cross-resistance to existing fungicides. It offers outstanding and long-lasting control of Asian rust in soybean.
May 13, 2013
18:24 EDTACMPAccess Midstream to host institutional investor and analyst meeting
Subscribe for More Information
08:47 EDTWMBWilliams price target raised to $45 from $39 at Argus
Argus increased its price target on Williams as the firm expects the company's margins to stabilize in late 2013 or early 2014 as NGL supply/demand ratios become more favorable. The firm thinks the company is poised to increase its dividend by 20% annually through 2015, and it keeps a Buy rating on the shares.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.